XBiotech Inc.
XBIT
$8.74
$0.3053.62%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -44.71% | 41.82% | 24.92% | 29.27% | 50.47% |
| Total Depreciation and Amortization | -2.03% | -41.14% | -40.17% | -37.61% | -36.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 72.45% | -66.36% | -116.98% | -77.76% | -249.85% |
| Change in Net Operating Assets | -18.34% | -28.18% | -108.93% | 6.84% | -38.73% |
| Cash from Operations | -8.50% | -29.30% | -67.01% | 6.15% | -79.87% |
| Capital Expenditure | 12.88% | 84.29% | -153.66% | 96.27% | 72.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 203.91% | -- | -- | -- |
| Cash from Investing | 97.06% | 203.49% | -153.66% | 96.27% | -720.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -63.77% | 64.37% | 122.54% | -106.56% | 1,136.69% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 33.54% | 190.15% | -50.85% | 6.59% | -72.23% |
